Home Page - CBA SF



2019 Chinese Bioscience Association Annual Conference AgendaTheme: From Disruptive Innovation to Real-World ApplicationsOpeningTimeTopicSpeaker8:00-8:30amRegistration, Breakfast, Network, and ExhibitionAll8:30-8:35amWelcome RemarksAC Chair – Dannis Chang, Pharm.D.8:35-8:40amState of the UnionPresident of CBA – Huifang Li, Ph.D.8:40-9:20amKeynote Presentation #1Brain Tech: The Example of EpilepsyDr. Robert Fisher, MD, PhD. Maslah Saul MD Professor and Director of the Stanford Epilepsy Center and EEG lab, Stanford UniversityMorning Session #1: Innovative Drug Discoveries and BreakthroughsTimeTopicSpeaker9:20-9:25amOpening Statements / Introduction of the SpeakersSession Chair: Wenyi Chen, Ph.D.9:25-9:50amNeuroregeneration Therapies for Neurodegenerative DisordersGong Chen, PhD. Verne M.?Willaman Chair Professor,??The Pennsylvania State UniversityFounder and CSO, NeuExcell Therapeutics Inc.9:50-10:15amIntegrate CRISPR genome editing and single-cell analysis to probe cancer evolutionLe Cong, PhD. Stanford Assistant Professor10:15-10:25amQ&AALL10:25-10:50amBreak, Network and ExhibitionMorning Session #2: Bench to BedsideTimeTopicSpeaker10:50-10:55amOpening Statements / Introduction of the SpeakersSession Chair: Sydney Chen, Ph.D.10:55-11:20amTBDCynthia Wong, VP of Portfolio planning and program management, Denali Therapeutics11:20-11:45amGlobalization of First in Human TrialsDan Zhang, MD, MPH, Executive Chairman, Fountain Medical Development, Ltd11:45-11:55amQ&AALL11:55-12:05pmScholarship Presentation12:05-1:00pmLunch, Network, and ExhibitionAfternoon OpeningTimeTopicSpeaker1:00-1:05pmWelcome Back, summary of morning sessionsAC Chair – Dannis Chang, Pharm.D.1:05-1:45pmKeynote Presentation #2 - Do Opposites (Finally) Attract?? How Tech is transforming Life SciencesTom Duley, Sidley Austin LLPAfternoon Session #1: AI and Innovative Diagnostic Tools and Technologies To Advancing HealthcareTimeTopicSpeaker1:45-1:50pmOpening Statements / Introduction of the SpeakersSession Chair: Dannis Chang, Pharm.D. 1:50-2:15pmTBD David Purdie, Ph.D.Vice President, Medical Affairs and Clinical Development at Proteus Digital Health2:15-2:40pmGenerating Efficacious Enzyme Therapeutics based on Knowledge Learned From Biocatalytic Pharmaceutical ManufactureXiang Yi, Ph.D. Scientist and Project leader from Codexis 2:40-3:05pmHow AI is Transforming the Pharmaceutical and Biotechnology SectorsPatricia Campbell, PhD., JD., Partner, Jones Day3:05-3:15pmQ&AALL3:15-3:30pmBreak, Network and ExhibitionAfternoon Session #2: Trends in Bio-Pharma Drug Development – Global Regulatory Considerations TimeTopicSpeaker3:30-3:35pmOpening Statements / Introduction of the SpeakersSession Chair and Moderator: Lin Sun-Hoffman, PhD, JD3:35-4:00pmInnovative drug regulation:Soft way to support hard scientific drug-able InnovationFrank Li, MD, PhD, Founder and CEO of BLA Regulatory, LLC4:00-4:30pmPanelists: Yong Ben, MD, MBA, CMO of Immuno-Oncology, BeiGeneFrank Li and TBDAfternoon Session #3: Biotech Investment, Deal Transaction and Entrepreneurship PanelTimeTopicSpeaker4:30-4:35pmOpening Statements / Introduction of the SpeakersSession Chair and Moderator: Michelle Chen, PhD 4:35-5:25pmPanelists: Alexis Ji (Illumina Ventures), Stella Xu (Quan Capital), Tom Duley (Sidley), Peter Li (Founding CEO of Turning Point Therapeutics)5:25-5:30pmConference End – Closing Remarks by AC Co-Chair – Wenyi Chen, Ph.D5:30-7:00pmNetworking Reception ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download